Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-14 of 14 for your search:
Drug:  polifeprosan 20 with carmustine implant
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NEOPHARM-IL13PEI-301, UCLA-040305101, NEOPHARM-IL13PEI-301-R01, PRECISE, NCT00076986

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 64
Sponsor: Pharmaceutical / Industry
Protocol IDs: NPC-08-1, NCT00919737

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9802, JHOC-NABTT-9802, NCT00003878

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: Pro00004127, DUMC-5515-06-1R2, DUMC-5515-04-1R0, GP-DUMC-5515-06-1R2, CDR0000483768, NCT00362921

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GLIA-001, NCT00525590

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: KARE003, NCT00660283

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1706, DUMC-1706-02-9R5, DUMC-1706-01-9R4, DUMC-000693-00-4, DUMC-1509-97-10, DUMC-1568-98-10R1, DUMC-1706-00-9R3, DUMC-97131, NCI-G98-1470, CDR0000066503, NCT00003467

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00025180, NCT01186406

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696316, CRUK-UCL-09-0398, 2010-022496-66, 09/0398, 10/H0304/100, UCL/09/0398 v2.0, GALA-5, EUDRACT-2010-022496-66, NCT01310868

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 0901, DUMC-0901-02-5R4, DUMC-0901-02-5R2, DUMC-000901-00-5R2, DUMC-000901-01-5R3, DUMC-0797-99-5RI, DUMC-796-98-5, DUMC-98065, UCLA-9812060, NCI-G98-1464, DUMC-0901-01-5R3, CDR0000066497, NCT00003463

11.

Phase: Phase I
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: RP-RPR132596-150MA, NCI-V98-1465

12.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCMC-98724, UCMC-55853, NCI-V99-1543, NCT00003876

13.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-IRB-9812061, NCI-G99-1600

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9803, JHOC-NABTT-9803, NCT00004892
New Search